XML 44 R38.htm IDEA: XBRL DOCUMENT v3.25.1
Equity Method Investment - Additional Information (Details) - USD ($)
$ / shares in Units, shares in Millions
 3 Months Ended
Dec. 02, 2024
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Schedule of Equity Method Investments [Line Items]        
Equity method investment dividends or distributions   $ 20,000,000    
Equity method investment dividends or distributions per unit   $ 1    
Common Stock, Par or Stated Value Per Share   $ 0.0001   $ 0.0001
Loss from equity method investment   $ (4,461,000) $ 0  
Research and development expenses   30,480,000 27,408,000  
Other income   266,000 $ (99,000)  
Accrued expenses   31,254,000   $ 29,972,000
Accounts payable   $ 17,834,000   $ 11,560,000
Huntsville Manufacturing Facility        
Schedule of Equity Method Investments [Line Items]        
Common units owned   20.0    
Common unit, price per unit   $ 1    
Percentage of the common units outstanding   100.00%    
Gannet BioChem        
Schedule of Equity Method Investments [Line Items]        
Fair value of investment $ 12,200,000      
Loss from equity method investment   $ (4,461,000)    
Minimum purchase commitments   0    
Purchases made   0    
Services Agreements        
Schedule of Equity Method Investments [Line Items]        
Accrued expenses   900,000    
Accounts payable   $ 500,000    
Services Agreements | Gannet BioChem        
Schedule of Equity Method Investments [Line Items]        
Agreement term   2 years    
Research and development expenses   $ 200,000    
Other income   300,000    
Net payable   $ 1,400,000    
Asset Acquisition By Ampersand Capital Partners | Huntsville Manufacturing Facility        
Schedule of Equity Method Investments [Line Items]        
Preferred units owned by a related party   81.5    
Preferred unit, price per unit owned by related party   $ 1    
Percentage of the preferred units owned by related party outstanding   100.00%    
Asset Acquisition By Ampersand Capital Partners | Asset Purchase Agreement | Huntsville Manufacturing Facility        
Schedule of Equity Method Investments [Line Items]        
Consideration in cash, net of transaction costs $ 64,700,000